TBX21 and tuberculosis: CD39 exhibited superior diagnostic accuracy over IFN-γ across multiple cohorts, with further improvement when combined with a TB-antigen-responsive gene (TBX21 or GZMB) for distinguishing TB from TBI/HC, highlighting its potential as a biomarker.